1. Home
  2. NNNN vs MQ Comparison

NNNN vs MQ Comparison

Compare NNNN & MQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • MQ
  • Stock Information
  • Founded
  • NNNN 2021
  • MQ 2010
  • Country
  • NNNN Germany
  • MQ United States
  • Employees
  • NNNN N/A
  • MQ N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MQ Computer Software: Prepackaged Software
  • Sector
  • NNNN Health Care
  • MQ Technology
  • Exchange
  • NNNN Nasdaq
  • MQ Nasdaq
  • Market Cap
  • NNNN 2.2B
  • MQ 1.9B
  • IPO Year
  • NNNN 2025
  • MQ 2021
  • Fundamental
  • Price
  • NNNN $42.80
  • MQ $5.53
  • Analyst Decision
  • NNNN
  • MQ Hold
  • Analyst Count
  • NNNN 0
  • MQ 13
  • Target Price
  • NNNN N/A
  • MQ $5.35
  • AVG Volume (30 Days)
  • NNNN 147.4K
  • MQ 4.4M
  • Earning Date
  • NNNN 01-01-0001
  • MQ 08-06-2025
  • Dividend Yield
  • NNNN N/A
  • MQ N/A
  • EPS Growth
  • NNNN N/A
  • MQ N/A
  • EPS
  • NNNN 0.06
  • MQ 0.11
  • Revenue
  • NNNN $8,185,146.00
  • MQ $528,100,000.00
  • Revenue This Year
  • NNNN N/A
  • MQ $18.12
  • Revenue Next Year
  • NNNN N/A
  • MQ $22.15
  • P/E Ratio
  • NNNN $776.89
  • MQ $51.71
  • Revenue Growth
  • NNNN 21.95
  • MQ N/A
  • 52 Week Low
  • NNNN $5.18
  • MQ $3.37
  • 52 Week High
  • NNNN $55.65
  • MQ $6.01
  • Technical
  • Relative Strength Index (RSI)
  • NNNN N/A
  • MQ 39.40
  • Support Level
  • NNNN N/A
  • MQ $5.77
  • Resistance Level
  • NNNN N/A
  • MQ $5.76
  • Average True Range (ATR)
  • NNNN 0.00
  • MQ 0.13
  • MACD
  • NNNN 0.00
  • MQ -0.05
  • Stochastic Oscillator
  • NNNN 0.00
  • MQ 10.04

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About MQ Marqeta Inc.

Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.

Share on Social Networks: